Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma

Journal of Clinical Oncology

Volumn 30, Issue 14, 2012, Pages 1635-1640

  Katsuya, Hiroo ^a   Yamanaka, Takeharu ^d   Ishitsuka, Kenji ^a   Utsunomiya, Atae ^e   Sasaki, Hidenori ^a   Hanada, Shuichi ^f   Eto, Tetsuya ^b   Moriuchi, Yukiyoshi ^g   Saburi, Yoshio ^h   Miyahara, Masaharu ⁱ   Sueoka, Eisaburo ^j   Uike, Naokuni ^c   Yoshida, Shinichiro ^k   Yamashita, Kiyoshi ^l   Tsukasaki, Kunihiro ⁿ   Suzushima, Hitoshi ^p   Ohno, Yuju ^q   Matsuoka, Hitoshi ^m   Jo, Tatsuro ^o   Suzumiya, Junji ^r   Tamura, Kazuo ^a   more..

^a FUKUOKA UNIVERSITY   (Japan)

^b HAMANOMACHI HOSPITAL   (Japan)

^c NATIONAL KYUSHU CANCER CENTER   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^e IMAMURA BUN IN HOSPITAL   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION KAGOSHIMA MEDICAL CENTER   (Japan)

^g Sasebo Shiritsu Sogo Hospital   (Japan)

^h OITA PREFECTURAL HOSPITAL   (Japan)

ⁱ KARATSU RED CROSS HOSPITAL   (Japan)

^j SAGA UNIVERSITY HOSPITAL   (Japan)

^k NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^l MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

^m Koga General Hospital   (Japan)

ⁿ NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^o JAPANESE RED CROSS NAGASAKI GENBAKU HOSPITAL   (Japan)

^p 11 40 Hijiyamahonmachi   (Japan)

^q KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

^r SHIMANE UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN; SOLUBLE INTERLEUKIN 2 RECEPTOR; ALBUMINOID; ANTINEOPLASTIC AGENT; INTERLEUKIN 2 RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; FEMALE; HUMAN; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSTIC INDEX FOR T CELL LEUKEMIA; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; T CELL LEUKEMIA; VALIDATION STUDY; AGE; BLOOD; CAUSE OF DEATH; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; JAPAN; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALBUMINS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAUSE OF DEATH; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, INTERLEUKIN-2; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863745306     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.2101     Document Type: Article

References (25)

1. Uchiyama T, Yodoi J, Sagawa K, et al: Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 50:481-492, 1977
2. Poiesz BJ, Ruscetti FW, Gazdar AF, et al: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77:7415-7419, 1980
3. Murphy EL, Hanchard B, Figueroa JP, et al: Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 43:250-253, 1989
4. Yamaguchi K, Watanabe T: Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int J Hematol 76:240-245, 2002 (suppl 2)
5. Ishitsuka K, Tamura K: Treatment of adult T-cell leukemia/lymphoma: Past, present, and future. Eur J Haematol 80:185-196, 2008
6. Major prognostic factors of patients with adult T-cell leukemia-lymphoma: A cooperative study - Lymphoma Study Group (1984-1987). Leuk Res 15:81-90, 1991
7. Shimoyama M: Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma: A report from the Lymphoma Study Group (1984-87). Br J Haematol 79:428-437, 1991
8. Yamada Y, Tomonaga M, Fukuda H, et al: A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113:375-382, 2001
9. Tsukasaki K, Utsunomiya A, Fukuda H, et al: VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25:5458-5464, 2007
10. Tsukasaki K, Hermine O, Bazarbachi A, et al: Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting. J Clin Oncol 27:453-459, 2009
11. Royston P, Altman DG, Sauerbrei W: Dichotomizing continuous predictors in multiple regression: A bad idea. Stat Med 25:127-141, 2006
12. Royston P, Sauerbrei W: Multivariable Modelbuilding: A Pragmatic Approach to Regression Analysis Based on Fractional Polynomials for Modelling Continuous Variables. Hoboken, NJ, Wiley, 2008
13. Sauerbrei W, Meier-Hirmer C, Benner A, et al: Multivariable regression model building by using fractional polynomials: Description of SAS, STATA and R programs. Comput Stat Data Anal 50:3464-3485, 2006
14. Bazarbachi A, Plumelle Y, Carlos Ramos J, et al: Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic sub-types. J Clin Oncol 28:4177-4183, 2010
15. A predictive model for aggressive non-Hodgkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987-994, 1993
16. Solal-Céligny P, Roy P, Colombat P, et al: Follicular lymphoma international prognostic index. Blood 104:1258-1265, 2004
17. Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339:1506-1514, 1998
18. Gallamini A, Stelitano C, Calvi R, et al: Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study. Blood 103:2474-2479, 2004
19. Lee J, Suh C, Park YH, et al: Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study. J Clin Oncol 24:612-618, 2006
20. Kamihira S, Atogami S, Sohda H, et al: Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 73:2753-2758, 1994
21. Araki K, Harada K, Nakamoto K, et al: Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers. Clin Exp Immunol 119:259-263, 2000
22. Suzumiya J, Ohshima K, Tamura K, et al: The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: Analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project. Ann Oncol 20:715-721, 2009
23. Kami M, Hamaki T, Miyakoshi S, et al: Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol 120:304-309, 2003
24. Fukushima T, Miyazaki Y, Honda S, et al: Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia 19: 829-834, 2005
25. Hishizawa M, Kanda J, Utsunomiya A, et al: Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: A nationwide retrospective study. Blood 116:1369-1376, 2010